| Profile for lybisimylysa |
|---|
|
SignatureLinezolid and daptomycin demonstrated similar rates of microbiological cure (89.4% vs. 86.5%; P = 0.67) and clinical success (50.0% vs. 64.7%; P = 0.19).A decision-analytic model was constructed from the hospital perspective to assess the cost-effectiveness of alternative empiric treatment options... |
